The key role of the KCC2/NKCC1 balance in the pathogenesis of various neurological disorders, including refractory epilepsy, neuropathic pain [25] and muscle spasticity due to spinal cord injury [17], makes these co-transporters important therapeutic targets for the treatment of neurological diseases. The gene discussed is AQP1; the disease is nervous system disorder.